13.67
price down icon2.01%   -0.28
after-market After Hours: 13.67
loading
Avalo Therapeutics Inc stock is traded at $13.67, with a volume of 273.87K. It is down -2.01% in the last 24 hours and up +28.30% over the past month. Avalo Therapeutics Inc is a clinical-stage biotechnology company focused on the treatment of immune dysregulation. The company's asset is AVTX-009, an anti-IL-1B monoclonal antibody ("mAb"), targeting inflammatory diseases. Avalo's pipeline also includes quisovalimab (anti-LIGHT mAb) and AVTX-008 (BTLA agonist fusion protein).
See More
Previous Close:
$13.95
Open:
$13.79
24h Volume:
273.87K
Relative Volume:
0.86
Market Cap:
$179.79M
Revenue:
$1.93M
Net Income/Loss:
$-7.96M
P/E Ratio:
-0.00387
EPS:
-3530.8178
Net Cash Flow:
$-36.78M
1W Performance:
-2.36%
1M Performance:
+28.30%
6M Performance:
+178.98%
1Y Performance:
+43.29%
1-Day Range:
Value
$13.20
$14.48
1-Week Range:
Value
$13.20
$15.99
52-Week Range:
Value
$3.39
$16.00

Avalo Therapeutics Inc Stock (AVTX) Company Profile

Name
Name
Avalo Therapeutics Inc
Name
Phone
410-522-8707
Name
Address
1500 LIBERTY RIDGE DRIVE, WAYNE
Name
Employee
23
Name
Twitter
Name
Next Earnings Date
2024-11-07
Name
Latest SEC Filings
Name
AVTX's Discussions on Twitter

Compare AVTX with other stocks

Stocks Price Market Cap Revenue Net Income Cash Flow EPS
Biotechnology icon
AVTX
Avalo Therapeutics Inc
13.67 248.31M 1.93M -7.96M -36.78M -3,530.82
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
407.37 104.55B 11.39B 3.64B 3.50B 13.99
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
464.95 60.36B 2.46B -319.09M -52.09M -2.4669
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
557.73 59.84B 14.21B 4.46B 3.56B 39.69
Biotechnology icon
ARGX
Argen X Se Adr
799.56 49.07B 3.06B 1.28B 447.35M 19.67
Biotechnology icon
ONC
Beone Medicines Ltd Adr
327.03 35.16B 4.56B -176.77M 225.30M -1.7177

Avalo Therapeutics Inc Stock (AVTX) Upgrades & Downgrades

Date Action Analyst Rating Change
Sep-17-25 Reiterated H.C. Wainwright Buy
Sep-05-25 Initiated TD Cowen Buy
Aug-15-25 Initiated Cantor Fitzgerald Overweight
Jun-02-25 Resumed H.C. Wainwright Buy
Mar-25-25 Initiated Jefferies Buy
Mar-25-25 Initiated Stifel Buy
Feb-28-25 Initiated Piper Sandler Overweight
Feb-21-25 Initiated Wedbush Outperform
Dec-19-24 Initiated BTIG Research Buy
Oct-24-24 Initiated H.C. Wainwright Neutral
Apr-16-24 Upgrade Oppenheimer Perform → Outperform
Sep-24-21 Initiated RBC Capital Mkts Outperform
View All

Avalo Therapeutics Inc Stock (AVTX) Latest News

pulisher
11:01 AM

Real time social sentiment graph for Avalo Therapeutics Inc.Portfolio Performance Report & Pattern Based Trade Signal System - newser.com

11:01 AM
pulisher
10:40 AM

Will Avalo Therapeutics Inc. stock keep outperforming rivalsJuly 2025 Momentum & Community Supported Trade Ideas - newser.com

10:40 AM
pulisher
10:29 AM

Will Avalo Therapeutics Inc. stock deliver long term returns2025 Valuation Update & Daily Chart Pattern Signal Reports - newser.com

10:29 AM
pulisher
10:28 AM

How Avalo Therapeutics Inc. (C6K0) stock responds to job market shiftsProfit Target & Fast Moving Trade Plans - newser.com

10:28 AM
pulisher
10:03 AM

Technical analysis overview for Avalo Therapeutics Inc. stockFed Meeting & Capital Efficient Trading Techniques - newser.com

10:03 AM
pulisher
09:09 AM

Why Avalo Therapeutics Inc. stock remains on watchlists2025 Momentum Check & Daily Stock Momentum Reports - newser.com

09:09 AM
pulisher
05:44 AM

Multi factor analysis applied to Avalo Therapeutics Inc.Weekly Trade Analysis & Risk Controlled Daily Trade Plans - newser.com

05:44 AM
pulisher
05:24 AM

Is it time to cut losses on Avalo Therapeutics Inc.July 2025 Snapshot & Capital Efficient Trading Techniques - newser.com

05:24 AM
pulisher
03:23 AM

Will Avalo Therapeutics Inc. stock benefit from upcoming earnings reportsEarnings Performance Report & Daily Oversold Stock Bounce Ideas - newser.com

03:23 AM
pulisher
01:15 AM

Avalo Therapeutics Inc. stock trend forecastMarket Movement Recap & Consistent Profit Trade Alerts - newser.com

01:15 AM
pulisher
Oct 11, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat

Oct 11, 2025
pulisher
Oct 10, 2025

How high can Avalo Therapeutics Inc. stock goJuly 2025 Macro Moves & Entry and Exit Point Strategies - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Avalo Therapeutics, Inc. Updates Investor Presentation - TradingView

Oct 10, 2025
pulisher
Oct 10, 2025

Should I buy Avalo Therapeutics Inc. (C6K0) stock before earnings season2025 Year in Review & Fast Entry and Exit Trade Plans - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

How Avalo Therapeutics Inc. stock performs in weak economyRecession Risk & Smart Swing Trading Techniques - newser.com

Oct 10, 2025
pulisher
Oct 10, 2025

Can Avalo Therapeutics Inc. stock outperform in 2025 bull marketJuly 2025 Analyst Calls & High Accuracy Swing Entry Alerts - newser.com

Oct 10, 2025
pulisher
Oct 09, 2025

Will Avalo Therapeutics Inc. see short term momentumWall Street Watch & Low Risk Growth Stock Ideas - newser.com

Oct 09, 2025
pulisher
Oct 06, 2025

Is Avalo Therapeutics Inc. (C6K0) stock positioned for secular growthRate Hike & Breakout Confirmation Alerts - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

How moving averages guide Avalo Therapeutics Inc. trading2025 Biggest Moves & AI Driven Stock Reports - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Can Avalo Therapeutics Inc. (C6K0) stock sustain revenue momentum2025 Technical Patterns & Reliable Price Action Trade Plans - newser.com

Oct 06, 2025
pulisher
Oct 06, 2025

Is Avalo Therapeutics Inc a good long term investmentRisk Mitigation Techniques & Free Superior Profit Margins - earlytimes.in

Oct 06, 2025
pulisher
Oct 03, 2025

Why Avalo Therapeutics Inc. (C6K0) stock remains top rated2025 Market Outlook & AI Forecasted Entry/Exit Points - newser.com

Oct 03, 2025
pulisher
Oct 03, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Sees Significant Increase in Short Interest - Defense World

Oct 03, 2025
pulisher
Oct 02, 2025

Avalo Therapeutics, Inc. (NASDAQ:AVTX) Short Interest Update - MarketBeat

Oct 02, 2025
pulisher
Oct 02, 2025

Avalo Therapeutics Strengthens Leadership with Key Appointments - The Globe and Mail

Oct 02, 2025
pulisher
Oct 02, 2025

Avalo Therapeutics Expands Leadership Team with Key - GlobeNewswire

Oct 02, 2025
pulisher
Oct 01, 2025

Avalo Therapeutics, Inc. Announces Board Appointments, Effective October 1, 2025 - MarketScreener

Oct 01, 2025
pulisher
Oct 01, 2025

Avalo Therapeutics expands leadership with two senior appointments By Investing.com - Investing.com Canada

Oct 01, 2025
pulisher
Oct 01, 2025

Avalo Therapeutics expands leadership with two senior appointments - Investing.com India

Oct 01, 2025
pulisher
Oct 01, 2025

Former Longboard $2.6B Deal Architect Joins Avalo Therapeutics as CBO Ahead of Key Trial Results - Stock Titan

Oct 01, 2025
pulisher
Oct 01, 2025

BTIG Research Reiterates “Buy” Rating for Avalo Therapeutics (NASDAQ:AVTX) - Defense World

Oct 01, 2025
pulisher
Sep 30, 2025

Avalo Therapeutics' (AVTX) Buy Rating Reiterated at BTIG Research - MarketBeat

Sep 30, 2025
pulisher
Sep 30, 2025

BTIG Reiterates Avalo Therapeutics (AVTX) Buy Recommendation - Nasdaq

Sep 30, 2025
pulisher
Sep 30, 2025

BTIG Maintains Avalo Therapeutics(AVTX.US) With Buy Rating, Maintains Target Price $40 - 富途牛牛

Sep 30, 2025
pulisher
Sep 29, 2025

What drives Avalo Therapeutics Inc stock priceSector Performance Drivers & Free Dashboard to Track Market Momentum - earlytimes.in

Sep 29, 2025
pulisher
Sep 29, 2025

What analysts say about Avalo Therapeutics Inc stockBlue Chip Stock Analysis & Superior Trading Ideas - earlytimes.in

Sep 29, 2025

Avalo Therapeutics Inc Stock (AVTX) Financials Data

Revenue

loading

Net Income

loading

Cash Flow

loading

EPS

loading

Avalo Therapeutics Inc Stock (AVTX) Insider Trading

Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total
Almenoff June Sherie
Director
Nov 12 '24
Buy
12.50
500
6,250
500
$84.73
price up icon 1.11%
$22.93
price up icon 7.40%
$32.68
price up icon 2.73%
$102.30
price up icon 0.24%
$163.94
price up icon 0.99%
biotechnology ONC
$327.03
price up icon 2.16%
Cap:     |  Volume (24h):